Found 11 matching trials
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) PHASE2 Single-arm, single site, open label study of the effects of parenteral test...
Show More Location
Sibley Memorial Hospital
Learn More & Join Trial
COMbination of Bipolar Androgen Therapy and Nivolumab PHASE2 Single arm, multicenter, open-label Phase II study of the effects of parent...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer PHASE3 ProBio is an international, outcome-adaptive, multi-arm, open-label, multip...
Show More Location
OLV Ziekenhuis Aalst
Learn More & Join Trial
Combination Study of Antibiotics With Enzalutamide (PROMIZE) PHASE1 PROMIZE is an open-label, multi-centre, single-arm, Phase I/II clinical tri...
Show More Location
Oncolgy Institute of Southern Switzerland (IOSI)
Learn More & Join Trial
A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects PHASE1 A study to evaluate the bioavailability (BA) of a single oral dose of MDV31...
Show More Location
Parexel International GmbH
Learn More & Join Trial
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer PHASE1 Background:
Enzalutamide is given to treat metastatic prostate cancer. But...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients PHASE1 A multiple dose relative bioavailability study in patients with prostate ca...
Show More Location
University of Colorado - Anschutz Medical Campus
Learn More & Join Trial
Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance PHASE2 Asymptomatic men with progressive metastatic Castration-resistant prostate ...
Show More Location
Unversity of Alabama
Learn More & Join Trial
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials N/A This study will follow men with metastatic castration resistant prostate ca...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression PHASE2 Asymptomatic men without pain due to prostate cancer progressing with metas...
Show More Location
University of California, San Diego (UCSD)
Learn More & Join Trial